Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
NevGold Intercepts 11.42 g/t AuEq Over 7.7 Meters Within 4.91 g/t AuEq Over 27.4 Meters ; Initial Antimony-Gold Mineral Resource Estimate On Schedule For Q2-2026 With Focus On Near-Term Antimony Production
CHARBONE confirme une nouvelle livraison d'hydrogene propre UHP en Ontario, renforcant son deploiement commercial dans ce marche strategique
CHARBONE Confirms a New Delivery of Clean UHP Hydrogen to Ontario, Strengthening its Commercial Deployment in this Strategic Market
